Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Benedict

Showing results (31-40 of 369) with videos related to

Pageof 37
Sort By:
Journal of the Neurological Sciences|April 22, 2006
Predicting neuropsychological abnormalities in multiple sclerosisRalph H B Benedict, Robert Zivadinov
Journal of Neurology|May 16, 2007
Reliability and validity of neuropsychological screening and assessment strategies in MSRalph H B Benedict, Robert Zivadinov
Iucrdata|November 7, 2022
1,2-Bis(pyridin-4-yl)ethene-4-hy-droxy-3-meth-oxy-benzoic acid (1/1)Devin J Angevine, Jason B Benedict
Structural Dynamics (Melville, N.Y.)|July 4, 2017
Preface to Special Topic: Transactions from the 66th Annual Meeting of the American Crystallographic AssociationArwen R Pearson, Jason B Benedict
Iucrdata|November 7, 2022
4,4'-(Ethene-1,2-diyl)dipyridinium bis(2-hy-droxy-3-meth-oxy-benzoate)Devin J Angevine, Jason B Benedict
Seminars in Neurology|January 18, 2007
Multiple sclerosisRalph H B Benedict, Julie H Bobholz
Neurology|January 25, 2015
Paradoxes in thalamic function and cognition in people with multiple sclerosis: less is moreDeclan T Chard, Ralph H B Benedict
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2012
Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?Ralph H B Benedict, Marc K Walton
Neurosci|November 1, 2024
Cognitive Relapse in Multiple Sclerosis: New Findings and Directions for Future ResearchZachary L Weinstock, Ralph H B Benedict
Neurology|September 30, 2010
Down a slippery slope: cognitive changes in pediatric MSLauren B Krupp, Ralph H B Benedict
Pageof 37

Showing results (31-40 of 369) with videos related to

Sort By:
Pageof 37
Journal of the Neurological Sciences|April 22, 2006
Predicting neuropsychological abnormalities in multiple sclerosisRalph H B Benedict, Robert Zivadinov
Journal of Neurology|May 16, 2007
Reliability and validity of neuropsychological screening and assessment strategies in MSRalph H B Benedict, Robert Zivadinov
Iucrdata|November 7, 2022
1,2-Bis(pyridin-4-yl)ethene-4-hy-droxy-3-meth-oxy-benzoic acid (1/1)Devin J Angevine, Jason B Benedict
Structural Dynamics (Melville, N.Y.)|July 4, 2017
Preface to Special Topic: Transactions from the 66th Annual Meeting of the American Crystallographic AssociationArwen R Pearson, Jason B Benedict
Iucrdata|November 7, 2022
4,4'-(Ethene-1,2-diyl)dipyridinium bis(2-hy-droxy-3-meth-oxy-benzoate)Devin J Angevine, Jason B Benedict
Seminars in Neurology|January 18, 2007
Multiple sclerosisRalph H B Benedict, Julie H Bobholz
Neurology|January 25, 2015
Paradoxes in thalamic function and cognition in people with multiple sclerosis: less is moreDeclan T Chard, Ralph H B Benedict
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2012
Evaluating cognitive outcome measures for MS clinical trials: what is a clinically meaningful change?Ralph H B Benedict, Marc K Walton
Neurosci|November 1, 2024
Cognitive Relapse in Multiple Sclerosis: New Findings and Directions for Future ResearchZachary L Weinstock, Ralph H B Benedict
Neurology|September 30, 2010
Down a slippery slope: cognitive changes in pediatric MSLauren B Krupp, Ralph H B Benedict
Pageof 37